levetiracetam 250 MG Tablet for Oral Suspension
- RxCUI
- 1736045
- RxNorm name
- levetiracetam 250 MG Tablet for Oral Suspension
- Display name
- levetiracetam 250 MG Tablet for Oral Suspension
- Full name
- levetiracetam 250 MG Tablet for Oral Suspension
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:19
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Spritam | LEVETIRACETAM | Aprecia Pharmaceuticals, LLC | be651c31-383f-11e4-916c-0800200c9a66 | 2025-10-13 | Warnings, Adverse reactions | 1736045 |
| Levetiracetam | LEVETIRACETAM | Prasco Laboratories | dd175fa3-1d7a-4542-affd-988ac5bba1db | 2025-07-01 | Warnings, Adverse reactions | 1736045 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| be651c31-383f-11e4-916c-0800200c9a66 | levETIRAcetam 250 MG Tablet for Oral Suspension [PSN] · levetiracetam 250 MG Tablet for Oral Suspension [SCD] · levetiracetam 250 MG Tablet for Oral Suspension [SY] | 3 | 29 | These highlights do not include all the information needed to use SPRITAM ® safely and effectively. See full prescribing information for SPRITAM. SPRITAM (levetiracetam) tablets, for oral suspension Initial U.S. Approval: 1999 | 20251013 |
| dd175fa3-1d7a-4542-affd-988ac5bba1db | levETIRAcetam 250 MG Tablet for Oral Suspension [PSN] · levetiracetam 250 MG Tablet for Oral Suspension [SCD] · levetiracetam 250 MG Tablet for Oral Suspension [SY] | 3 | 3 | These highlights do not include all the information needed to use LEVETIRACETAM TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for LEVETIRACETAM TABLETS FOR ORAL SUSPENSION. Levetiracetam tablets, for oral suspension Initial U.S. Approval: 1999 | 20250701 |